NJ Court Shuts Down Suits Over Hormone Therapy Labeling
A New Jersey appeals court on Thursday affirmed the dismissal of a pair of tort suits accusing two Pfizer Inc. subsidiaries of failing to provide sufficient warning about the breast cancer...To view the full article, register now.
Already a subscriber? Click here to view full article